15 Biggest Mid-Day Losers For Wednesday

by Lisa Levin, Benzinga Editor
December 21, 2016 1:05 PM | 2 min read |
  • xG Technology Inc XGTI shares dropped 54.4 percent to $1.65 after the company reported the pricing of its $10 million offering.
  • Modsys International Ltd MDSY shares tumbled 18 percent to $0.992. Modsys shares have dipped 40.64 percent over the past 52 weeks, while the S&P 500 index has gained 12.35 percent in the same period.
  • Merrimack Pharmaceuticals Inc MACK declined 17.9 percent to $4.41 after the company announced that it will stop a Phase 2 study of its treatment to fight breast cancer.
  • Vanguard Natural Resources, LLC VNR shares fell 15.8 percent to $0.850. Vanguard Natural shares have declined 63.54 percent over the past 52 weeks, while the S&P 500 index has gained 12.35 percent in the same period.
  • ContraVir Pharmaceuticals Inc CTRV shares dropped 13.3 percent to $1.47.
  • Finish Line Inc FINL shares tumbled 12 percent to $20.25 after the company reported weaker-than-expected results for its fiscal third quarter and issued a downbeat forecast.
  • Long Island Iced Tea Corp LTEA shares dipped 11.8 percent to $4.20. Long Island Iced Tea priced an underwritten public offering of 399,050 shares at $4.00 per share.
  • RedHill Biopharma Ltd - ADR RDHL declined 10.6 percent to $9.66. RedHill Biopharma reported a proposed concurrent public offering and registered direct offering.
  • Lindsay Corporation LNN shares dropped 9 percent to $77.63 after the company posted downbeat Q1 results.
  • Delcath Systems, Inc. DCTH shares fell 9 percent to $1.11. Delcath Systems shares have dropped 86.14 percent over the past 52 weeks, while the S&P 500 index has increased 12.35 percent in the same period.
  • Advanced Accelerator Application SA(ADR) AAAP shares declined 5.4 percent to $24.79 after the company disclosed that it has received a Complete Response Letter from the FDA for Lutathera.
  • Accenture Plc ACN fell 4.2 percent to $118.95 after the company issued a weak outlook for the full year.
  • New York Community Bancorp, Inc. NYCB shares dropped 4.2 percent to $16.05. FBR Capital, Morgan Stanley and Raymond James downgraded New York Community Bancorp.
  • Lexicon Pharmaceuticals, Inc. LXRX shares slipped 3.4 percent to $15.78 after the company disclosed that its Phase 3 trial for sotagliflozin met its primary endpoint.
  • FedEx Corporation FDX fell 2.6 percent to $193.60 after the company reported weaker-than-expected earnings for its second quarter on Tuesday.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsMovers & ShakersIntraday UpdateMarketsBiotechnologyConstruction & Farm Machinery & Heavy TrucksHealth CareIndustrialsMid-Day LosersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!